Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

Kazu Gomi, president and CEO of NTT Research, has a big view of the technology world from his perch in Silicon Valley.

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

Col. Craig A. Bonham II. The presentations showcased Picatinny’s efforts in leading the research, development, and engineering of critical military technologies, and described as a testament to ...

The solutions include: (i) research on major development issues facing Africa and their relation to global economic governance and other major global public goods; (ii) country diagnostics and future ...

The UK government's net expenditure on research and development (R&D) rose to £17.4 billion in 2023 from £16.1 billion in 2022, an increase of 8.2%. UK Research and Innovation (UKRI), excluding ...

With its Artificial Intelligence Platform (AIP), Palantir aspires to change code development as we know it. Launched in April 2023, AIP is in the process of putting a fork in the road of code ...

However, increased uncertainty due to the expected reduction in official development assistance poses a significant challenge to sustaining these achievements. Political relations in the region are ...

Last April 3, we witnessed another milestone in our commitment to serving our kababayans and ensuring the country's sustainable growth and development ... believe that CDCs are not mere buildings but ...

"Reduced research funding means we are delaying the development and refinement of treatments that could delay or prevent the onset of dementia symptoms, reducing quality of life and increasing ...